La chaîne d'options affiche les données clés des options sur actions de SILO Pharma à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour SILO Pharma..

SILO Pharma (NASDAQ:SILO) Stock, Chaîne d'Options

SILO Pharma

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

SILO Pharma Inc

Silo Wellness Inc

FTCI

Trading Halt: Halted at 4:50:00 p.m. ET - Trading Halt: Halt News Pending

<p>Citigroup  analyst Yigal Nochomovitz   maintains Applied Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) with a Buy and lowers the price target from $13 to $8.</p>


News

Price Target

Analyst Ratings

APLT

Citigroup Maintains Buy on Applied Therapeutics, Lowers Price Target to $8

<p>JP Morgan  analyst Lisa Gill   maintains Privia Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVA#NASDAQ">PRVA</a>) with a Overweight and raises the price target from $27 to $28.</p>


PRVA

JP Morgan Maintains Overweight on Privia Health Gr, Raises Price Target to $28

<p>JP Morgan  analyst Jeremy Tonet   maintains Kodiak Gas Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGS#NYSE">KGS</a>) with a Neutral and raises the price target from $34 to $42.</p>


JP Morgan Maintains Neutral on Kodiak Gas Services, Raises Price Target to $42

<p>The Q3 earnings report for <strong>Globus Maritime</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBS#NASDAQ">GLBS</a>) was released on Friday, November 29, 2024 at 04:00 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Globus Maritime beat estimated earnings by 70.0%, reporting an EPS of $-0.03 versus an estimate of $-0.1.</p>
<p>Revenue was up $1.27 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company beat on EPS by $0.12 in the previous quarter, leading to a 2.0% increase share price change the next day.</p>
<p>Here's a look at Globus Maritime's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
<th><strong>Q3 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.04</td>
<td>-0.02</td>
<td>-0.10</td>
<td></td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.16</td>
<td>-0.01</td>
<td>0.02</td>
<td>0.17</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>7.80M</td>
<td>8.00M</td>
<td>5.80M</td>
<td>12.30M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>9.52M</td>
<td>7.71M</td>
<td>7.11M</td>
<td>7.68M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Globus Maritime <a href="https://www.benzinga.com/quote/GLBS/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

GLBS

Globus Maritime: Q3 Earnings Insights

<h3>Gainers</h3>
<ul>
<li><strong>Lion Group Holding</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGHL#NASDAQ">LGHL</a>) shares increased by 22.5% to $0.21 during Friday's pre-market session. The market value of their outstanding shares is at $5.1 million. </li>
<li><strong>X Financial</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYF#NYSE">XYF</a>) shares increased by 14.32% to $8.3. The market value of their outstanding shares is at $393.5 million. As per the news, the Q3 earnings report came out 3 days ago. </li>
<li><strong>Patriot Ntl Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNBK#NASDAQ">PNBK</a>) stock rose 9.99% to $1.98. The company's market cap stands at $7.8 million. </li>
<li><strong>XChange Tec</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XHG#NASDAQ">XHG</a>) shares rose 9.74% to $1.69. The company's market cap stands at $190.3 million. </li>
<li><strong>Berkshire Hills Bancorp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHLB#NYSE">BHLB</a>) shares rose 6.79% to $33.0. The company's market cap stands at $1.4 billion. </li>
<li><strong>Kingstone Companies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KINS#NASDAQ">KINS</a>) shares rose 6.58% to $17.0. The market value of their outstanding shares is at $209.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Inter &amp; Co</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTR#NASDAQ">INTR</a>) stock decreased by 16.7% to $4.4 during Friday's pre-market session. The company's market cap stands at $1.9 billion. </li>
<li><strong>Hilltop Hldgs</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HTH#NYSE">HTH</a>) stock fell 15.67% to $26.82. The company's market cap stands at $1.7 billion. </li>
<li><strong>XP</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XP#NASDAQ">XP</a>) stock decreased by 9.37% to $13.55. The company's market cap stands at $7.2 billion. </li>
<li><strong>Bank Bradesco</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBDO#NYSE">BBDO</a>) stock fell 8.42% to $1.85. The market value of their outstanding shares is at $19.6 billion. </li>
<li><strong>StoneCo</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>) shares fell 8.36% to $9.54. The market value of their outstanding shares is at $2.9 billion. </li>
<li><strong>Essent Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESNT#NYSE">ESNT</a>) stock declined by 8.2% to $53.01. The company's market cap stands at $5.6 billion.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Movers

BBDO

BHLB

ESNT

INTR

KINS

LGHL

PNBK

STNE

12 Financials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li><strong>Super Hi International</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDL#NASDAQ">HDL</a>) stock increased by 15.1% to $19.48 during Friday's pre-market session. The company's market cap stands at $1.1 billion. As per the news, the Q3 earnings report came out 4 days ago. </li>
<li><strong>Leslies</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) shares rose 8.86% to $2.7. The market value of their outstanding shares is at $499.3 million. As per the press release, Q4 earnings came out 4 days ago. </li>
<li><strong>Foresight Autonomous</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSX#NASDAQ">FRSX</a>) stock moved upwards by 8.19% to $0.66. The company's market cap stands at $10.1 million. </li>
<li><strong>Jianzhi Education Tech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) stock increased by 8.15% to $1.11. The market value of their outstanding shares is at $31.2 million. </li>
<li><strong>Lottery.com</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) stock increased by 7.98% to $0.35. The market value of their outstanding shares is at $3.4 million. </li>
<li><strong>Birks Group</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BGI#AMEX">BGI</a>) stock increased by 7.86% to $1.7. The company's market cap stands at $32.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Dogness (Intl)</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOGZ#NASDAQ">DOGZ</a>) stock fell 14.4% to $44.4 during Friday's pre-market session. The market value of their outstanding shares is at $565.2 million. </li>
<li><strong>EpicQuest Education Group</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEIQ#NASDAQ">EEIQ</a>) stock declined by 10.37% to $0.92. The market value of their outstanding shares is at $11.9 million. </li>
<li><strong>Ambow Education Holding</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AMBO#AMEX">AMBO</a>) stock fell 10.16% to $1.77. The market value of their outstanding shares is at $5.0 million. </li>
<li><strong>Interactive Strength</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares declined by 9.86% to $3.11. The company's market cap stands at $2.8 million. </li>
<li><strong>Mynd.ai</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYND#AMEX">MYND</a>) stock declined by 6.75% to $2.15. The company's market cap stands at $98.1 million. </li>
<li><strong>Vroom</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRM#NASDAQ">VRM</a>) stock fell 6.04% to $4.98. The company's market cap stands at $9.0 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AMBO

DOGZ

EEIQ

FRSX

LESL

LTRY

MYND

TRNR

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li><strong>Cabaletta Bio</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CABA#NASDAQ">CABA</a>) shares rose 26.9% to $3.82 during Friday's pre-market session. The market value of their outstanding shares is at $186.6 million. </li>
<li><strong>Biomerica</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRA#NASDAQ">BMRA</a>) stock increased by 19.74% to $0.39. The market value of their outstanding shares is at $6.4 million. </li>
<li><strong>Passage Bio</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PASG#NASDAQ">PASG</a>) stock rose 17.01% to $0.78. The company's market cap stands at $48.1 million. </li>
<li><strong>SILO Pharma</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) stock rose 14.44% to $1.03. The market value of their outstanding shares is at $4.6 million. </li>
<li><strong>Alterity Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) stock increased by 12.84% to $1.23. The market value of their outstanding shares is at $10.7 million. </li>
<li><strong>IO Biotech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>) shares rose 11.76% to $0.95. The company's market cap stands at $62.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>Applied Therapeutics</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>) stock fell 74.5% to $2.19 during Friday's pre-market session. The market value of their outstanding shares is at $254.8 million. </li>
<li><strong>Journey Medical</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DERM#NASDAQ">DERM</a>) stock declined by 13.52% to $4.8. The market value of their outstanding shares is at $100.2 million. </li>
<li><strong>Grifols</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRFS#NASDAQ">GRFS</a>) shares declined by 12.64% to $7.05. The company's market cap stands at $4.7 billion. </li>
<li><strong>Nutriband</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRB#NASDAQ">NTRB</a>) stock fell 12.38% to $4.25. The company's market cap stands at $47.1 million. </li>
<li><strong>TC BioPharm (Holdings)</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) stock declined by 10.37% to $0.54. </li>
<li><strong>Accuray</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAY#NASDAQ">ARAY</a>) shares declined by 9.96% to $1.9. The company's market cap stands at $191.0 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ARAY

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BMRA

CABA

DERM

GRFS

IOBT

NTRB

PASG

SILO

TCBP

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li><strong>Unusual Machines</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UMAC#AMEX">UMAC</a>) stock rose 44.8% to $14.32 during Friday's pre-market session. The company's market cap stands at $118.8 million. </li>
<li><strong>Ondas Holdings</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) stock rose 31.53% to $1.14. The market value of their outstanding shares is at $88.1 million. </li>
<li><strong>NextTrip</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRP#NASDAQ">NTRP</a>) stock moved upwards by 20.0% to $3.6. The company's market cap stands at $5.1 million. </li>
<li><strong>The9</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCTY#NASDAQ">NCTY</a>) shares increased by 8.44% to $14.44. The market value of their outstanding shares is at $129.7 million. </li>
<li><strong>Couchbase</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) stock moved upwards by 8.21% to $22.0. The market value of their outstanding shares is at $1.1 billion. </li>
<li><strong>Red Cat Hldgs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) stock moved upwards by 7.87% to $10.0. The company's market cap stands at $754.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li><strong>T Stamp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDAI#NASDAQ">IDAI</a>) shares declined by 23.8% to $0.64 during Friday's pre-market session. The company's market cap stands at $14.8 million. </li>
<li><strong>Karooooo</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) stock declined by 11.86% to $39.1. The market value of their outstanding shares is at $1.2 billion. </li>
<li><strong>ZenaTech</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) shares declined by 11.36% to $6.95. The market value of their outstanding shares is at $122.7 million. </li>
<li><strong>Infobird Co</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) shares fell 9.1% to $2.4. The market value of their outstanding shares is at $4.7 million. </li>
<li><strong>Luna Innovations</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNA#NASDAQ">LUNA</a>) stock fell 8.99% to $1.62. The company's market cap stands at $56.2 million. </li>
<li><strong>Oblong</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLG#NASDAQ">OBLG</a>) stock decreased by 7.41% to $3.25. The company's market cap stands at $3.7 million.<br />
<strong>See Also:</strong> <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BASE

IDAI

IFBD

KARO

LUNA

NCTY

NTRP

OBLG

ONDS

RCAT

UMAC

ZENA

12 Information Technology Stocks Moving In Friday's Pre-Market Session

<p><strong>Ares Capital's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARCC#NYSE">ARCC</a>) short percent of float has fallen 10.33% since its last report. The company recently reported that it has <strong>15.59 million shares sold short</strong>, which is 2.43% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 4.14 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Ares Capital Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732913119_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Ares Capital has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Ares Capital's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Ares Capital's peer group average for short interest as a percentage of float is 3.34%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

Trading Ideas

ARCC

(ARCC) - Analyzing Ares Capital's Short Interest

<p><strong>United Parcel Service's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) short percent of float has risen 12.83% since its last report. The company recently reported that it has <strong>15.39 million shares sold short</strong>, which is 2.11% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 4.38 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>United Parcel Service Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732913115_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for United Parcel Service has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing United Parcel Service's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, United Parcel Service's peer group average for short interest as a percentage of float is 3.22%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


(UPS) - Analyzing United Parcel Service's Short Interest

<p><strong>Service Corp Intl's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCI#NYSE">SCI</a>) short percent of float has fallen 8.9% since its last report. The company recently reported that it has <strong>7.71 million shares sold short</strong>, which is 6.14% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 7.66 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Service Corp Intl Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732913109_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Service Corp Intl has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Service Corp Intl's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Service Corp Intl's peer group average for short interest as a percentage of float is 5.26%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Peering Into Service Corp Intl's Recent Short Interest

<p>Financial giants have made a conspicuous bullish move on Chipotle Mexican Grill. Our analysis of options history for Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) revealed 8 unusual trades.</p>
<p>Delving into the details, we found 75% of traders were bullish, while 12% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $73,306, and 6 were calls, valued at $549,253.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $52.0 to $65.0 for Chipotle Mexican Grill over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Chipotle Mexican Grill's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Chipotle Mexican Grill's whale trades within a strike price range from $52.0 to $65.0 in the last 30 days. </p>
<h3>Chipotle Mexican Grill Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732912264_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$10.3</td>
<td>$10.2</td>
<td>$10.3</td>
<td>$52.00</td>
<td>$288.4K</td>
<td>11.5K</td>
<td align="right">280</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$5.6</td>
<td>$5.4</td>
<td>$5.5</td>
<td>$60.00</td>
<td>$110.0K</td>
<td>2.9K</td>
<td align="right">200</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$11.2</td>
<td>$11.0</td>
<td>$11.2</td>
<td>$62.50</td>
<td>$53.7K</td>
<td>1.2K</td>
<td align="right">169</td>
</tr>
<tr>
<td>CMG</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$8.2</td>
<td>$7.7</td>
<td>$7.85</td>
<td>$60.00</td>
<td>$39.2K</td>
<td>429</td>
<td align="right">50</td>
</tr>
<tr>
<td>CMG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$11.2</td>
<td>$11.0</td>
<td>$11.2</td>
<td>$62.50</td>
<td>$38.0K</td>
<td>1.2K</td>
<td align="right">74</td>
</tr>
</tbody>
</table>
</p>
<h3>About Chipotle Mexican Grill</h3>
<p>Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $9.9 billion in 2023. The Mexican concept is almost exclusively company-owned, with just two license stores opearted through a master franchise relationship with Alshaya Group in the Middle East. It had a footprint of nearly 3,440 stores at the end of 2023, heavily indexed to the United States, although it maintains a small presence in Canada, the UK, France, and Germany. Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.</p>
<p>Having examined the options trading patterns of Chipotle Mexican Grill, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Present Market Standing of Chipotle Mexican Grill</h3>
<ul>
<li>Trading volume stands at 3,818,457, with CMG's price down by -0.84%, positioned at $61.53.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 67 days.</li>
</ul>
<h3>What The Experts Say On Chipotle Mexican Grill</h3>
<p>2 market experts have recently issued ratings for this stock, with a consensus target price of $67.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from RBC Capital downgraded its action to Outperform with a price target of $70.<br />
&#x2A; Reflecting concerns, an analyst from Stephens &amp; Co. lowers its rating to Equal-Weight with a new price target of $65.</p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Chipotle Mexican Grill with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

Smart Money Is Betting Big In CMG Options

<p>Benzinga's options scanner just detected over 8 options trades for <strong>Freeport-McMoRan</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) summing a total amount of $246,685.</p>
<p>At the same time, our algo caught 4 for a total amount of 193,380.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $65.0 for Freeport-McMoRan over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of Freeport-McMoRan stands at 746.43, with a total volume reaching 3,859.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Freeport-McMoRan, situated within the strike price corridor from $40.0 to $65.0, throughout the last 30 days.</p>
<h3>Freeport-McMoRan Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732912259_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$6.3</td>
<td>$6.15</td>
<td>$6.3</td>
<td>$47.00</td>
<td>$79.3K</td>
<td>182</td>
<td align="right">126</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$4.2</td>
<td>$4.0</td>
<td>$4.0</td>
<td>$44.00</td>
<td>$50.8K</td>
<td>463</td>
<td align="right">127</td>
</tr>
<tr>
<td>FCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.3</td>
<td>$7.25</td>
<td>$7.3</td>
<td>$45.00</td>
<td>$40.8K</td>
<td>1.9K</td>
<td align="right">504</td>
</tr>
<tr>
<td>FCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$7.25</td>
<td>$7.2</td>
<td>$7.25</td>
<td>$45.00</td>
<td>$35.5K</td>
<td>1.9K</td>
<td align="right">370</td>
</tr>
<tr>
<td>FCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$21.35</td>
<td>$21.25</td>
<td>$21.25</td>
<td>$65.00</td>
<td>$34.0K</td>
<td>152</td>
<td align="right">16</td>
</tr>
</tbody>
</table>
</p>
<h3>About Freeport-McMoRan</h3>
<p>Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2023, making it the one of the world's largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. About 75% of 2023 revenue was from copper, with a further 15% from gold and about 10% from molybdenum. It had about 25 years of copper reserves at end December 2023. We expect it to sell similar amounts of copper midcycle in 2028, though we expect gold volumes to decline to about 700,000 ounces then due to falling production at Grasberg.</p>
<p>Having examined the options trading patterns of Freeport-McMoRan, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of Freeport-McMoRan</h3>
<ul>
<li>Trading volume stands at 6,511,840, with FCX's price up by 1.27%, positioned at $44.31.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 54 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Freeport-McMoRan, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Unpacking the Latest Options Trading Trends in Freeport-McMoRan

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Caterpillar</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CAT, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 18 uncommon options trades for Caterpillar.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 33% bullish and 55%, bearish.</p>
<p>Out of all of the special options we uncovered, 4 are puts, for a total amount of $360,704, and 14 are calls, for a total amount of $851,386.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $155.0 and $430.0 for Caterpillar, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Caterpillar's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Caterpillar's substantial trades, within a strike price spectrum from $155.0 to $430.0 over the preceding 30 days.</p>
<h3>Caterpillar Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732912254_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$4.0</td>
<td>$3.6</td>
<td>$4.0</td>
<td>$410.00</td>
<td>$200.8K</td>
<td align="right">92</td>
<td align="right">596</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$14.65</td>
<td>$14.45</td>
<td>$14.65</td>
<td>$420.00</td>
<td>$183.1K</td>
<td align="right">197</td>
<td align="right">126</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$28.0</td>
<td>$25.8</td>
<td>$28.0</td>
<td>$400.00</td>
<td>$140.0K</td>
<td align="right">623</td>
<td align="right">0</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$47.8</td>
<td>$46.65</td>
<td>$47.8</td>
<td>$420.00</td>
<td>$109.9K</td>
<td align="right">373</td>
<td align="right">23</td>
</tr>
<tr>
<td>CAT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$18.9</td>
<td>$16.95</td>
<td>$18.9</td>
<td>$420.00</td>
<td>$75.2K</td>
<td align="right">378</td>
<td align="right">80</td>
</tr>
</tbody>
</table>
</p>
<h3>About Caterpillar</h3>
<p>Caterpillar is the top manufacturer of heavy equipment, power solutions, and locomotives. It is currently the world's largest manufacturer of heavy equipment. The company is divided into four reportable segments: construction industries, resource industries, energy and transportation, and Cat Financial. Its products are available through a dealer network that covers the globe with about 2,700 branches maintained by 160 dealers. Cat Financial provides retail financing for machinery and engines to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Caterpillar product sales.</p>
<h3>Caterpillar's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,961,635, the price of CAT is up by 0.61%, reaching $406.16.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 66 days from now.</li>
</ul>
<h3>What The Experts Say On Caterpillar</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $348.75.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from Evercore ISI Group lowers its rating to Underperform with a new price target of $365.<br />
&#x2A; An analyst from UBS persists with their Sell rating on Caterpillar, maintaining a target price of $295.<br />
&#x2A; An analyst from Baird persists with their Underperform rating on Caterpillar, maintaining a target price of $300.<br />
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Caterpillar, which currently sits at a price target of $435. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Caterpillar, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Check Out What Whales Are Doing With CAT

<p><a href="https://www.benzinga.com/personal-finance/24/03/37740851/give-everything-to-us-now-gen-zs-main-career-goal-is-to-make-lots-of-money-so-they-can-be-richer">Gen Z workers</a> are entering the workforce with high hopes and ambitions, but the transition isn't going as planned for many.&nbsp;</p>
<p>A September survey published by Intelligent.com found that 60% of employers have already let go of Gen Z hires just months after they started. The reasons are piling up: <a href="https://www.benzinga.com/personal-finance/24/10/41555075/millennials-and-gen-z-rely-on-parents-for-financial-support-survey-finds-its-costing-them-their-">lack of motivation</a>, poor communication skills and unprofessional behavior are at the top of the list. Employers have also flagged issues like tardiness, inappropriate workplace attire and unrealistic expectations for quick promotions.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><strong>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"><strong> The percentage may shock you</strong></a>.</strong></li>
<li><strong>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"><strong> </strong><strong>How do you compare</strong></a>?</strong></li>
</ul>
<p>Recruiters and hiring managers aren't just frustrated; they're rethinking whether it's worth hiring recent graduates. One in six employers say they're hesitant to bring on new grads and some companies outright avoid them in next year's hiring cycle.</p>
<p>According to a New York Post article, the disconnect doesn't seem limited to the U.S. Recruitment expert Roxanne Calder observes similar trends in Australia, though not as severe as in America. She notes that employers are frustrated because younger hires often fail to meet the expectations tied to their starting salaries – many of which hover around $80,000 for entry-level roles. Companies are looking for employees who can "fire" on all cylinders immediately, but Calder says many Gen Z workers lack the technical and interpersonal skills to meet these demands.</p>
<p><strong>See Also: Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2"><strong>with $1,000 you can invest at just $0.26/share!</strong></a></strong></p>
<p>In her experience, one of the biggest challenges is how Gen Z handles feedback. "They find it really difficult," she told news.com.au, as the New York Post reported.&nbsp;</p>
<p>Sometimes, Calder converses with young workers and then sends them an email asking if they have anything to add because she finds they struggle so much with face-to-face communication. This hesitancy to engage directly with managers and process constructive criticism creates a significant gap between employer expectations and employee readiness.</p>
<p>Feedback has also become a sticking point; Calder notes that Gen Z workers often struggle to take constructive criticism, which can create friction with managers.</p>
<p><a href="https://www.benzinga.com/general/24/06/39181971/gen-z-job-applicant-rejects-90-minute-task-ceo-faces-backlash">Adding fuel to the fire</a>, TikTok is full of Gen Z employees sharing their stories about being fired. Some blame rigid or outdated workplace cultures, while others admit they weren't prepared for the reality of their roles. Calder says, "They want the dream career, but when the reality hits, it's hard to reconcile the two."</p>
<p><strong>Trending: Over the last five years, the price of gold has increased by approximately 83% — Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold"><strong>create customized gold IRAs to help shield their savings from inflation and economic turbulence.&nbsp;</strong></a></strong></p>
<p>But the finger-pointing can't rest solely on Gen Z. HR consultant Bryan Driscoll argues that the education system shoulders some responsibility. In a Newsweek article, Driscoll drew on personal experience, stating, "As someone who went through years of education, including law school, I can tell you this: colleges are not preparing students for real-world work."</p>
<p>Companies, too, could step up by offering better onboarding and mentorship programs to set young hires up for success. Driscoll warns, "If companies keep treating them as disposable assets, we're going to end up with a workforce that's both overworked and unprepared."</p>
<p>Bridging the gap will ultimately <a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved">require effort on both sides</a>. Employers need to invest in the next generation and Gen Z workers need to adapt to the demands of the professional world. Until then, the revolving door of new hires and rapid terminations will likely keep spinning.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"><strong> </strong><strong>to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</strong></a></strong></li>
<li><strong>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"><strong> </strong><strong>here&#8217;s a breakdown on what&#8217;s behind this formula.</strong></a></strong></li>
</ul>


Personal Finance

Gen Zers Are Being Fired Just Months After Getting Hired – Employers Cite Lack Of Motivation, Poor Communication And Unprofessional Behavior

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/LMLLF"><strong>Pharmadrug</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 63.33% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/MGWFF"><strong>Maple Leaf Green World</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed up 39.35% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/LVRLF"><strong>CordovaCann</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 32.00% at $0.07</li>
<li><a href="https://www.benzinga.com/quote/CNPOF"><strong>RIV Capital</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 19.77% at $0.09</li>
<li><a href="https://www.benzinga.com/quote/CNTMF"><strong>Cansortium</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 18.92% at $0.11</li>
<li><a href="https://www.benzinga.com/quote/FFNTF"><strong>4Front Ventures</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 11.32% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/KAYS"><strong>Kaya Holdings</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed up 7.04% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/SOLCF"><strong>SOL Glb Inv</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed up 5.49% at $0.15</li>
<li><a href="https://www.benzinga.com/quote/ITHUF"><strong>iAnthus Capital Hldgs</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 4.35% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CARA"><strong>Cara Therapeutics</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 3.26% at $0.30</li>
<li><a href="https://www.benzinga.com/quote/NWVCF"><strong>EnWave</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.12% at $0.14</li>
<li><a href="https://www.benzinga.com/quote/SOL"><strong>Emeren Group</strong></a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) shares closed up 3.09% at $1.90</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ALEAF"><strong>Aleafia Health</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALEAF#OTC">ALEAF</a>) shares closed down 99.00% at $1e-06</li>
<li><a href="https://www.benzinga.com/quote/RMHB"><strong>Rocky Mountain High</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed down 51.19% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CNBX"><strong>CNBX Pharmaceuticals</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed down 13.79% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BBRRF"><strong>Blueberries Medical</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed down 9.30% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CURR"><strong>Currenc Group</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed down 7.95% at $1.79</li>
<li><a href="https://www.benzinga.com/quote/CLSH"><strong>CLS Holdings USA</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CLSH#OTC">CLSH</a>) shares closed down 5.62% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/XXII"><strong>22nd Century Group</strong></a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) shares closed down 5.21% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/CURLF"><strong>Curaleaf Holdings</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) shares closed down 4.60% at $1.93</li>
<li><a href="https://www.benzinga.com/quote/TGIFF"><strong>1933 Industries</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed down 3.64% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/BLOZF"><strong>Cannabix Technologies</strong></a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed down 3.23% at $0.28</li>
</ul>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Cannabis

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

BBRRF

BLOZF

CARA

CLSH

CNBX

CNPOF

CNTMF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

FFNTF

ITHUF

KAYS

LMLLF

LVRLF

MGWFF

NWVCF

RMHB

SOLCF

TGIFF

XXII

Cannabis Stock Gainers And Losers From November 29, 2024

<p><strong><em>Via <a href="https://elplanteo.com/venderan-semillas-de-cannabis-psicoactivo-en-uruguay/">El Planteo</a></em></strong></p>
<p><strong>Mercedes Ponce de León,</strong> founder of <strong><a href="https://elplanteo.com/expocannabis-uruguay-2024/">ExpoCannabis Uruguay</a></strong>, announced that &#8220;On Friday, December 6, at ExpoCannabis Uruguay, at 1 p.m., we will make history with the launch of the first pre-sale of legal psychoactive cannabis seeds in Uruguay.&#8221; This milestone cements Uruguay's position as a global cannabis industry leader.</p>
<p>The news, shared exclusively during <a href="https://www.youtube.com/watch?v=3ouJLpCZvIA">El Planteo Live #23</a>, opens new doors for consumers and local businesses. Ponce de León explained that this initiative, spearheaded by <strong>Antera Garden Supplies</strong> in collaboration with seed bank <strong>Ripper Seeds,</strong> will offer legal psychoactive varieties. She added, "This is a revolutionary change in Uruguay&#8217;s cannabis history."</p>
<h1 class="wp-block-heading"><strong>Uruguay: A Pioneer Facing New Challenges</strong></h1>
<p>Since legalizing cannabis production, commercialization and consumption in 2013, Uruguay has led the way in the region. The country has gained recognition for exporting medical cannabis flowers and industrial hemp, with companies striving for a global presence.</p>
<p>However, challenges persist, particularly in navigating international regulations and securing financing.</p>
<p><strong>See Also: <a href="https://www.benzinga.com/government/regulations/24/11/41996451/uruguays-cannabis-industry-struggles-amid-export-barriers-price-drops" target="_blank" rel="noreferrer noopener">Uruguay's Cannabis Industry Struggles Amid Export Barriers, Price Drops</a></strong></p>
<h1 class="wp-block-heading"><strong>ExpoCannabis: Driving Industry Transformation</strong></h1>
<p>ExpoCannabis Uruguay has been a key event for the cannabis industry since its inception. More than just a networking opportunity, the event acts as a springboard for regulatory and commercial breakthroughs.</p>
<p>Ponce de León highlighted the importance of this year's edition, where the pre-sale of seeds takes center stage, promising to reshape the landscape for local consumers and growers. She noted, "ExpoCannabis has always been a platform for innovation, and this year will be no different."</p>
<p>The event's significance lies in its ability to generate impact both nationally and internationally. It attracts investors, experts and companies who view Uruguay as a model to emulate.</p>
<h1 class="wp-block-heading"><strong>The Future Of Cannabis In Uruguay</strong></h1>
<p>Despite its accomplishments, Uruguay faces growing competition from countries such as Colombia and Mexico, which are advancing in cannabis production and exportation. To maintain its leadership, Uruguay must continue innovating, diversifying its markets and addressing regulatory challenges with clear strategies.</p>
<p>The pre-sale of legal seeds marks just the beginning. As Ponce de León summarized, "This is the start of a new chapter for Uruguay's cannabis sector."</p>
<p><strong>Read Next: </strong><br />    •&nbsp;<strong><a href="https://www.benzinga.com/markets/cannabis/24/11/42249515/10-years-of-legal-weed-in-uruguay-will-the-new-government-expand-access">10+ Years Of Legal Weed In Uruguay: Will The New Government Expand Access?</a></strong></p>
<p><em>Photo courtesy Javier Hasse.</em></p>


Latin America

Global

Exclusives

EXCLUSIVE: Psychoactive Cannabis Seeds To Be Sold Legally In Uruguay For The First Time

<p>Financial giants have made a conspicuous bearish move on JD.com. Our analysis of options history for JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) revealed 26 unusual trades.</p>
<p>Delving into the details, we found 34% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 16 were puts, with a value of $713,824, and 10 were calls, valued at $4,563,272.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $50.0 for JD.com during the past quarter. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for JD.com's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of JD.com's whale activity within a strike price range from $20.0 to $50.0 in the last 30 days. </p>
<h3>JD.com 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732911341_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$17.75</td>
<td>$17.4</td>
<td>$17.52</td>
<td>$20.00</td>
<td>$877.2K</td>
<td>2.8K</td>
<td>1.0K</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$17.5</td>
<td>$17.4</td>
<td>$17.5</td>
<td>$20.00</td>
<td>$875.0K</td>
<td>2.8K</td>
<td>2.0K</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$17.7</td>
<td>$17.5</td>
<td>$17.5</td>
<td>$20.00</td>
<td>$875.0K</td>
<td>2.8K</td>
<td>1.5K</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$17.55</td>
<td>$17.5</td>
<td>$17.5</td>
<td>$20.00</td>
<td>$875.0K</td>
<td>2.8K</td>
<td>501</td>
</tr>
<tr>
<td>JD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$9.2</td>
<td>$8.85</td>
<td>$9.05</td>
<td>$30.00</td>
<td>$452.5K</td>
<td>4.3K</td>
<td>1.5K</td>
</tr>
</tbody>
</table>
</p>
<h3>About JD.com</h3>
<p>JD.com is a leading e-commerce platform with its 2022 China GMV being similar to Pinduoduo (GMV not reported), on our estimate, but still lower than Alibaba. it offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.</p>
<p>Following our analysis of the options activities associated with JD.com, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of JD.com</h3>
<ul>
<li>With a volume of 6,017,846, the price of JD is up 0.65% at $37.43. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 96 days.</li>
</ul>
<h3>What The Experts Say On JD.com</h3>
<p>2 market experts have recently issued ratings for this stock, with a consensus target price of $49.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Citigroup persists with their Buy rating on JD.com, maintaining a target price of $51.<br />
&#x2A; In a cautious move, an analyst from Benchmark downgraded its rating to Buy, setting a price target of $47. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for JD.com, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


This Is What Whales Are Betting On JD.com

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Microsoft</strong>.</p>
<p>Looking at options history for Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) we detected 126 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 61% of the investors opened trades with bullish expectations and 31% with bearish.</p>
<p>From the overall spotted trades, 8 are puts, for a total amount of $302,871 and 118, calls, for a total amount of $7,229,628.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $190.0 to $460.0 for Microsoft over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Microsoft's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Microsoft's substantial trades, within a strike price spectrum from $190.0 to $460.0 over the preceding 30 days.</p>
<h3>Microsoft Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1732911336_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$76.7</td>
<td>$76.55</td>
<td>$76.7</td>
<td>$350.00</td>
<td>$138.0K</td>
<td>7.0K</td>
<td>33</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$48.4</td>
<td>$47.8</td>
<td>$48.13</td>
<td>$380.00</td>
<td>$120.3K</td>
<td>4.8K</td>
<td>45</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$1.55</td>
<td>$1.52</td>
<td>$1.55</td>
<td>$430.00</td>
<td>$108.5K</td>
<td>6.1K</td>
<td>6.2K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$22.85</td>
<td>$22.75</td>
<td>$22.75</td>
<td>$420.00</td>
<td>$100.1K</td>
<td>6.6K</td>
<td>242</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$221.1</td>
<td>$219.15</td>
<td>$220.2</td>
<td>$215.00</td>
<td>$88.0K</td>
<td>59</td>
<td>34</td>
</tr>
</tbody>
</table>
</p>
<h3>About Microsoft</h3>
<p>Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).</p>
<h3>Current Position of Microsoft</h3>
<ul>
<li>With a trading volume of 16,259,550, the price of MSFT is up by 0.02%, reaching $423.08.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 60 days from now.</li>
</ul>
<h3>What The Experts Say On Microsoft</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $496.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Microsoft, maintaining a target price of $548.<br />
&#x2A; An analyst from Piper Sandler has decided to maintain their Overweight rating on Microsoft, which currently sits at a price target of $470.<br />
&#x2A; An analyst from RBC Capital downgraded its action to Outperform with a price target of $500.<br />
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Microsoft, maintaining a target price of $465.<br />
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Microsoft with a target price of $500. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Microsoft options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


MSFT

Behind the Scenes of Microsoft's Latest Options Trends

Silo Pharma files to sell 1.04M shares of common stock for holders

Silo Pharma, Aeon Biopharma, and NaaS Technology are the 3 Penny Stocks to watch on July 18, based on&nbsp;TipRanks' Penny Stock Screener tool. Pen...

3 Penny Stocks to Watch Now, 7/18/24

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Developmental-stage pharmaceutical firm <strong>Silo Pharma</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/silo-stock-quote/"><strong>SILO</strong></a>) &mdash; which specializes in both traditional and psychedelic therapeutics to address stress-induced psychiatric disorders &mdash; saw its shares rise dramatically on Thursday. Earlier this morning, the company announced a partnership to develop an intranasal drug to address post-traumatic stress disorder (PTSD). The news and the large addressable market appears to have catapulted SILO stock.</p>



<p>According to Silo&rsquo;s <a href="https://finance.yahoo.com/news/silo-pharma-resyca-bv-partner-122500980.html">press release</a>, the pharmaceutical firm entered into a partnership with <strong>Resyca BV</strong>, a medical technology provider. Resyca itself is a joint venture which manufactures a formulation-specific microchip-based spray system &mdash; a system that undergirds Silo&rsquo;s lead candidate called SPC-15. This therapeutic addresses PTSD through &ldquo;cutting-edge nose-to-brain drug dispersion,&rdquo; explained Silo CEO Eric Weisblum.</p>



<p>In addition, the head executive added that &ldquo;this delivery method could increase the drug&rsquo;s concentration in the brain to deliver a faster onset of therapeutic benefit and optimized safety for PTSD patients.&rdquo;</p>



<p>Importantly, Silo and Resyca have developed a plan to set the framework for pre-human clinical trials. Such trials are necessary before the partnership can apply for an investigational new drug (IND) from the Food and Drug Administration (FDA) to conduct human trials.</p>



<h2>Growing Need for PTSD Solutions Fuels the Surge in SILO Stock</h2>



<p>Naturally, the anticipation of a regulatory green light has contributed to the explosive sentiment in SILO stock. A few days ago, the underlying pharma made headlines when it announced a <a href="https://investorplace.com/2024/07/why-is-silo-pharma-silo-stock-up-123-today/">licensing deal</a> for the development of SPC-14, a therapeutic for Alzheimer&rsquo;s.</p>



<p>Regarding today&rsquo;s jump in SILO stock, the growing need for addressing PTSD has helped positively shift the underlying corporate narrative. Prior to the series of key developments, Silo suffered a significant drop in equity value in the past one-year period. Now, in the past five sessions, SILO has gained 260%.</p>



<p>According to Grand View Research, the global PTSD treatment market size <a href="https://www.grandviewresearch.com/industry-analysis/post-traumatic-stress-disorder-treatment-market-report">reached a valuation of $915.5 million in 2021</a>. Experts project a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030. At the culmination point, the sector could generate revenue of $1.4 billion. However, it&rsquo;s also possible that this projection may be understated.</p>



<p>Presently, about one in five adults in the U.S. experience some form of <a href="https://magazine.howard.edu/stories/the-growth-of-mental-health-awareness#:~:text=and%20self%2Dcare.-,With%201%20in%205%20adults%20in%20the%20United%20States%20experiencing,wellness%2C%20especially%20on%20social%20media.">mental illness</a>. Further, as people &mdash; especially younger generations &mdash; become more vocal about mental wellness issues, demand for treatment solutions may rise. That&rsquo;s also another potential catalyst for SILO stock.</p>



<p><em><strong>On Penny Stocks and Low-Volume Stocks:</strong>&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em><strong>Read More:</strong>&#8239;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>



<p><em>On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.</em></p>
<div><p>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/07/why-is-silo-pharma-silo-stock-up-60-today/">Why Is Silo Pharma (SILO) Stock Up 60% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Why Is Silo Pharma (SILO) Stock Up 60% Today?

Silo Pharma stock plummets on $2.1M registered direct offering priced ATM

Silo Pharma announces partnership with global CRO for central nervous system homing peptide

Silo Pharma files for secondary stock offering

Silo Pharma ( ($SILO) ) has shared an update. Silo Pharma, Inc. has released a presentation outlining its strategic direction and product pipeline,...

Silo Pharma Outlines Strategic Direction and Innovative Pipeline

Silo Pharma (SILO) announced promising results from recent sterilization and dissolution tests of its SP-26 ketamine-loaded implant for fibromyalgi...

Silo Pharma reports results in sterilization, dissolution testing of SP-26

The company states: "Silo Pharma (SILO) announced promising results from a preclinical study on SPC-15. This new formulation, which targets both th...

Silo Pharma discloses 'promising results' from preclinical study on SPC-15

Silo Pharma (SILO) announced a collaboration agreement with Kymanox for specialized design and development of a subcutaneous insertion device for S...

Silo Pharma enters joint development agreement with Kymanox

AEON

NAAS

Screenshot 2024-05-21 at 6.46.56 PM

Biotech

General

ATAI

FTRP

Revolutionizing Mental Healthcare With The Rise Of Ketamine And Psychedelic Therapies

Health Care

Press Releases

Silo Pharma and Resyca BV Partner on Device and CMC Development for Intranasal PTSD Drug SPC-15

Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference

Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide

Contracts

Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic

Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD

Silo Pharma Reports Positive Results in Sterilization and Dissolution Testing of SP-26 Ketamine Implant

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management

Comments

SILO Pharma

SILO Pharma (SILO) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL